Olympus Corporation (OCPNF)
USD 15.5
(0.0%)
USD 15.5
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 190.03 Billion JPY | 16.59% |
| 2023 | 162.99 Billion JPY | -2.61% |
| 2022 | 167.36 Billion JPY | 5.33% |
| 2021 | 158.89 Billion JPY | -5.19% |
| 2020 | 167.59 Billion JPY | 9.1% |
| 2019 | 153.62 Billion JPY | 10.28% |
| 2018 | 139.3 Billion JPY | 11.16% |
| 2017 | 125.31 Billion JPY | 12.34% |
| 2016 | 111.55 Billion JPY | 3.88% |
| 2015 | 107.38 Billion JPY | 8.92% |
| 2014 | 98.59 Billion JPY | -0.72% |
| 2013 | 99.3 Billion JPY | -3.11% |
| 2012 | 102.49 Billion JPY | 10.29% |
| 2011 | 92.92 Billion JPY | 2.47% |
| 2010 | 90.69 Billion JPY | -6.01% |
| 2009 | 96.49 Billion JPY | -12.93% |
| 2008 | 110.82 Billion JPY | 23.35% |
| 2007 | 89.84 Billion JPY | -3.6% |
| 2006 | 93.19 Billion JPY | -9.33% |
| 2005 | 102.79 Billion JPY | 17.55% |
| 2004 | 87.44 Billion JPY | 13.32% |
| 2003 | 77.16 Billion JPY | -7.1% |
| 2002 | 83.06 Billion JPY | -24.65% |
| 2001 | 110.24 Billion JPY | 0.0% |
| 2000 | - JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 183.43 Billion JPY | 3.35% |
| 2024 Q1 | 177.48 Billion JPY | 8.89% |
| 2024 FY | 190.03 Billion JPY | 16.59% |
| 2024 Q4 | 190.03 Billion JPY | 1.88% |
| 2024 Q3 | 186.51 Billion JPY | 1.68% |
| 2023 Q2 | 171.18 Billion JPY | -8.4% |
| 2023 FY | 162.99 Billion JPY | -2.61% |
| 2023 Q4 | 162.99 Billion JPY | -4.63% |
| 2023 Q1 | 186.87 Billion JPY | 11.66% |
| 2023 Q3 | 170.91 Billion JPY | -0.16% |
| 2022 FY | 167.36 Billion JPY | 5.33% |
| 2022 Q1 | 164.05 Billion JPY | 3.19% |
| 2022 Q3 | 166.95 Billion JPY | 0.55% |
| 2022 Q2 | 166.04 Billion JPY | 1.21% |
| 2022 Q4 | 167.36 Billion JPY | 0.25% |
| 2021 Q2 | 160.85 Billion JPY | -12.25% |
| 2021 Q1 | 183.31 Billion JPY | 9.38% |
| 2021 FY | 158.89 Billion JPY | -5.19% |
| 2021 Q4 | 158.98 Billion JPY | -0.3% |
| 2021 Q3 | 159.45 Billion JPY | -0.87% |
| 2020 Q3 | 167.85 Billion JPY | 3.37% |
| 2020 Q1 | 162.43 Billion JPY | 5.74% |
| 2020 Q4 | 167.59 Billion JPY | -0.16% |
| 2020 Q2 | 162.37 Billion JPY | -0.03% |
| 2020 FY | 167.59 Billion JPY | 9.1% |
| 2019 Q4 | 153.62 Billion JPY | -0.81% |
| 2019 FY | 153.62 Billion JPY | 10.28% |
| 2019 Q2 | 152.14 Billion JPY | 3.94% |
| 2019 Q1 | 146.37 Billion JPY | 5.07% |
| 2019 Q3 | 154.87 Billion JPY | 1.8% |
| 2018 Q2 | 142.77 Billion JPY | 2.72% |
| 2018 Q1 | 139 Billion JPY | 10.92% |
| 2018 FY | 139.3 Billion JPY | 11.16% |
| 2018 Q4 | 139.3 Billion JPY | -5.31% |
| 2018 Q3 | 147.11 Billion JPY | 3.04% |
| 2017 Q3 | 129.51 Billion JPY | 12.08% |
| 2017 Q2 | 115.55 Billion JPY | 1.57% |
| 2017 Q1 | 113.76 Billion JPY | 1.34% |
| 2017 FY | 125.31 Billion JPY | 12.34% |
| 2017 Q4 | 125.31 Billion JPY | -3.24% |
| 2016 Q1 | 112.53 Billion JPY | 4.79% |
| 2016 Q4 | 112.26 Billion JPY | -0.07% |
| 2016 Q2 | 110.33 Billion JPY | -1.96% |
| 2016 FY | 111.55 Billion JPY | 3.88% |
| 2016 Q3 | 112.34 Billion JPY | 1.83% |
| 2015 Q1 | 106.52 Billion JPY | 8.04% |
| 2015 FY | 107.38 Billion JPY | 8.92% |
| 2015 Q2 | 114.25 Billion JPY | 7.26% |
| 2015 Q3 | 119.94 Billion JPY | 4.98% |
| 2015 Q4 | 107.38 Billion JPY | -10.47% |
| 2014 Q4 | 98.59 Billion JPY | -8.92% |
| 2014 FY | 98.59 Billion JPY | -0.72% |
| 2014 Q3 | 108.25 Billion JPY | 4.5% |
| 2014 Q2 | 103.58 Billion JPY | 0.96% |
| 2014 Q1 | 102.59 Billion JPY | 3.31% |
| 2013 Q2 | 98.42 Billion JPY | -5.54% |
| 2013 Q1 | 104.2 Billion JPY | 1.67% |
| 2013 FY | 99.3 Billion JPY | -3.11% |
| 2013 Q4 | 99.3 Billion JPY | -7.43% |
| 2013 Q3 | 107.28 Billion JPY | 9.0% |
| 2012 Q2 | 102.93 Billion JPY | 1.57% |
| 2012 Q3 | 103.95 Billion JPY | 0.98% |
| 2012 Q4 | 102.49 Billion JPY | -1.4% |
| 2012 FY | 102.49 Billion JPY | 10.29% |
| 2012 Q1 | 101.34 Billion JPY | 9.06% |
| 2011 FY | 92.92 Billion JPY | 2.47% |
| 2011 Q2 | 96.03 Billion JPY | 1.76% |
| 2011 Q3 | 94.6 Billion JPY | -1.49% |
| 2011 Q4 | 92.92 Billion JPY | -1.77% |
| 2011 Q1 | 94.36 Billion JPY | 4.05% |
| 2010 Q1 | 98.17 Billion JPY | 1.75% |
| 2010 FY | 90.69 Billion JPY | -6.01% |
| 2010 Q3 | 89.87 Billion JPY | 2.64% |
| 2010 Q4 | 90.69 Billion JPY | 0.91% |
| 2010 Q2 | 87.55 Billion JPY | -10.81% |
| 2009 Q3 | 105.03 Billion JPY | -3.25% |
| 2009 FY | 96.49 Billion JPY | -12.93% |
| 2009 Q2 | 108.55 Billion JPY | 0.0% |
| 2009 Q4 | 96.49 Billion JPY | -8.13% |
| 2008 FY | 110.82 Billion JPY | 23.35% |
| 2007 FY | 89.84 Billion JPY | -3.6% |
| 2006 FY | 93.19 Billion JPY | -9.33% |
| 2005 FY | 102.79 Billion JPY | 17.55% |
| 2004 FY | 87.44 Billion JPY | 13.32% |
| 2003 FY | 77.16 Billion JPY | -7.1% |
| 2002 FY | 83.06 Billion JPY | -24.65% |
| 2001 FY | 110.24 Billion JPY | 0.0% |
| 2000 FY | - JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -141994534.945% |
| Ansell Limited | 457.04 Million USD | -41478.149% |
| Ansell Limited | 457.9 Million USD | -41400.328% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -438407.498% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -681355224.489% |
| Psykey, Inc. | 49.94 Thousand USD | -380516519.944% |
| ConvaTec Group Plc | 395.54 Million USD | -47943.095% |
| ConvaTec Group Plc | 396.1 Million USD | -47875.259% |
| Encision Inc. | 1.4 Million USD | -13550841.357% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 2044652563.955% |
| LifePoint, Inc. | 2.3 Million USD | -8228647.31% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -7907931.627% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -43090602.948% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -206819516.465% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -19544420.016% |
| SmileDirectClub, Inc. | 49.87 Million USD | -380920.171% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | -53924.305% |
| SheerVision, Inc. | 339.66 Thousand USD | -55946529.453% |
| United Health Products, Inc. | 33.59 Thousand USD | -565599042.806% |
| Vasamed, Inc. | 449.02 Thousand USD | -42320200.738% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -2221274008.708% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -58983737.876% |